Ocular Hypertension Completed Phase 4 Trials for Brinzolamide (DB01194)

Also known as: Intraocular pressure raised / Ocular Hypertension (OHT) / Hypertension Ocular / Hypertension, Ocular / Intraocular pressure high / Intraocular hypertension / Ocular Hypertension (OH) / Elevated intraoccular pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02419508SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)Treatment
NCT00471380A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular HypertensionTreatment
NCT00761995Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular HypertensionTreatment
NCT01978600Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01937312Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin AnalogueTreatment
NCT01937299Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®Treatment
NCT01263444Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin TherapyTreatment
NCT01340014Patient Preference Comparison of AZARGA Versus COSOPTTreatment
NCT01415401Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in CanadaTreatment
NCT00675207Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin AnalogsTreatment
NCT01111890Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular HypertensionTreatment
NCT00440141Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%Treatment
NCT00300079Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular HypertensionTreatment